We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Coral-Inspired Capsule Samples Hidden Bacteria from Small Intestine

By LabMedica International staff writers
Posted on 08 Sep 2025

The gut microbiome has been linked to conditions ranging from immune disorders to mental health, yet conventional stool tests often fail to capture bacterial populations in the small intestine. More...

This region, the body’s largest mucosal surface, is crucial for host-microbiome interactions, metabolism, and immunity, but remains difficult to access. Researchers have now developed a swallowable capsule that passively collects microbes from the upper digestive tract, offering a clearer view of hidden bacterial communities missed by conventional stool tests.

The device, called the CORAL (Cellularly Organized Repeating Lattice) capsule, was developed by researchers from NYU Tandon School of Engineering (Brooklyn, NY, USA) in collaboration with NYU Abu Dhabi (Abu Dhabi, UAE). Inspired by the porous structures of marine corals, it is fabricated in a single 3D printing step and contains no moving parts, electronics, or magnets. Its design is based on mathematically defined Triply Periodic Minimal Surfaces (TPMS), forming a maze-like lattice that traps bacteria while allowing safe passage through the digestive tract.

A special coating ensures the capsule only begins sampling once it reaches the small intestine, preventing contamination from stomach acid. In animal studies, the capsule successfully captured distinct microbial populations that differed significantly from fecal samples. The findings, published in Device, showed higher levels of beneficial bacteria such as Lactobacillus, demonstrating that the capsule can reveal microbial communities missed by conventional methods.

The capsule’s simplicity and scalability make it a promising tool for microbiome research and clinical diagnostics. Unlike existing devices, it provides a non-invasive, passive method to map microbial ecosystems in situ. Researchers plan to scale the capsule to pill size, develop reliable retrieval methods, and conduct safety testing ahead of human trials.

"We designed CORAL to be as simple as possible, no batteries or electronics, just a mathematically precise structure that uses the gut's natural movement to sample bacteria," said Hanan Mohammed, lead author of the study. "It gives us access to bacterial communities that have been invisible to researchers until now."

Related Links:
NYU Tandon School of Engineering
NYU Abu Dhabi


New
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
Portable Electronic Pipette
Mini 96
New
Clinical Chemistry System
P780
New
Sample Transportation System
Tempus1800 Necto
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The VENTANA HER2 (4B5) test is now CE-IVDR approved (Photo courtesy of Roche)

Companion Diagnostic Test Identifies HER2-Ultralow Breast Cancer and Biliary Tract Cancer Patients

Breast cancer is the most common cancer in Europe, with more than 564,000 new cases and 145,000 deaths annually. Metastatic breast cancer is rising in younger populations and remains the leading cause... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.